Amphotericin B Aggregation Inhibition with Novel Nanoparticles Prepared with Poly(-caprolactone)/Poly(N,N-dimethylamino-2-ethyl methacrylate) Diblock Copolymer |
Shim, Yong-Ho
(Laboratory of Polymeric and Composite Materials, Center for Innovation and Research in Materials and Polymers (CIRMAP), University of Mons-Hainaut)
Kim, You-Chan (Department of Food Science and Biotechnology, Sungkyunkwan University) Lee, Hong-Joo (Gwangju Development Institute) Bougard, Francois (Laboratory of Polymeric and Composite Materials, Center for Innovation and Research in Materials and Polymers (CIRMAP), University of Mons-Hainaut) Dubois, Philippe (Laboratory of Polymeric and Composite Materials, Center for Innovation and Research in Materials and Polymers (CIRMAP), University of Mons-Hainaut) Choi, Ki-Choon (Grassland and Forages Research Center, National Institute of Animal Science, Rural Development Administration) Chung, Chung-Wook (National Research and Development Center for Hepatobiliary Disease, Pusan National University Yangsan Hospital) Kang, Dae-Hwan (National Research and Development Center for Hepatobiliary Disease, Pusan National University Yangsan Hospital) Jeong, Young-Il (National Research and Development Center for Hepatobiliary Disease, Pusan National University Yangsan Hospital) |
1 | Bougard, F., C. Giacomelli, L. Mespouille, R. Borsali, Ph. Dubois, and R. Lazzaroni. 2008. Influence of the macromolecular architecture on the self-assembly of amphiphilic copolymers based on poly(N,N-dimethylamino-2-ethyl methacrylate) and poly(-caprolactone). Langmuir 24: 8272-8279. DOI ScienceOn |
2 | Spasova, M., L. Mespouille, O. Coulembier, D. Paneva, N. Manolova, I. Rashkov, and P. Dubois. 2009. Amphiphilic poly(D-or L-lactide)-b-poly(N,N-dimethylamino-2-ethyl methacrylate) block copolymers: Controlled synthesis, characterization, and stereocomplex formation. Biomacromolecules 10: 1217-1223. DOI ScienceOn |
3 | Choi, K. C., J. Y. Bang, P. I. Kim, C. Kim, and C. E. Song. 2008. Amphotericin B-incorporated polymeric micelles composed of poly(D,L-lactide-co-glycolide)/dextran graft copolymer. Int. J. Pharm. 355: 224-230. DOI |
4 | Deray, G. 2002. Amphotericin B nephrotoxicity. J. Antimicrob. Chemother. 49: 37-41. DOI ScienceOn |
5 | Deshpande, M. C., M. C. Davies, M. C. Garnett, P. M. Williams, D. Armitage, L. Bailey, M. Vamvakaki, S. P. Armes, and S. Stolnik. 2004. The effect of poly(ethylene glycol) molecular architecture on cellular interaction and uptake of DNA complexes J. Control. Release 97: 143-156. DOI ScienceOn |
6 | Dupont, B. 2002. Overview of the lipid formulations of amphotericin B. J. Antimicrob. Chemother. 49(Suppl S1): 31-36. |
7 | Gallis, H. A., R. H. Drew, and W. W. Pickard. 1990. Amphotericin B: 30 years of clinical experience. Rev. Infect. Dis. 12: 308-329. DOI |
8 | Gref, R., Y. Minamitake, M. T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer. 1994. Biodegradable long-circulating polymeric nanospheres. Science 263: 1600-1603. DOI |
9 | Jeong, Y. I., J. B. Cheon, S. H. Kim, J. W. Nah, Y. M. Lee, Y. K. Sung, T. Akaike, and C. S. Cho. 1998. Clonazepam release from core-shell type nanoparticles in vitro. J. Control. Release 5: 169-178. |
10 | Ichinose, K., N. Tomiyama, M. Nakashima, Y. Ohya, M. Ichikawa, T. Ouchi, and T. Kanematsu. 2000. Antitumor activity of dextran derivatives immobilizing platinum complex (II). Anticancer Drugs 11: 33-38. DOI ScienceOn |
11 | Jeong, Y. I., M. K. Kang, H. S. Sun, S. S. Kang, H. W. Kim, K. S. Moon, K. J. Lee, S. H. Kim, and S. Jung. 2004. All-transretinoic acid release from core-shell type nanoparticles of poly(-caprolactone)/poly(ethylene glycol) diblock copolymer. Int. J. Pharm. 273: 95-107. DOI |
12 | Kataoka, K., G. S. Kwon, M. Yokohama, T. Okano, and Y. Sakurai. 1993. Block copolymer micelles as vehicles for drug delivery. J. Control. Release 24: 119-132. DOI ScienceOn |
13 | Kwon, G. S., M. Naito, M. Yokoyama, T. Okano, Y. Sakurai, and K. Kataoka. 1995. Physical entrapment of adriamycin in AB block copolymer micelles. Pharm. Res. 12: 192-195. DOI ScienceOn |
14 | Larabi, M., V. Yardley, P. M. Loiseau, M. Appel, P. Legrand, A. Gulik, C. Bories, S. L. Croft, and G. Barrat. 2003. Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B. Antimicrob. Agents Chemother. 47: 3774-3779. DOI ScienceOn |
15 | Berman, J. D. 1997. Human leishmaniasis: Clinical, diagnostic and chemotherapeutic developments in past 10 years. Clin. Infect. Dis. 24: 684-703. DOI ScienceOn |
16 | Groll, A. H. and T. J. Walsh. 2001. Uncommon opportunistic fungi: New nosocomial threats. Clin. Microbiol. Infect. 7(Suppl 2): 8-24. |
17 | Adams, M. L. and G. S. Kwon. 2003. Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: Effects of acyl chain length. J. Control. Release 87: 23-32. DOI |
18 | Barwicz, J., S. Christian, and I. Gruda. 1992. Effects of aggregation of amphotericin B on its toxicity to mice. Antimicrob. Agents Chemother. 36: 2310-2315. DOI ScienceOn |
19 | Bolard, J., P. Legrand, F. Heitz, and B. Cybulska. 1991. Onesided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium. Biochemistry 30: 5707-5715. DOI ScienceOn |
20 | Bougard, F., M. Jeusette, L. Mespouille, P. Dubois, and R. Lazzaroni. 2007. Synthesis and supramolecular organization of amphiphilic diblock copolymers combining poly(N,N-dimethylamino- 2-ethyl methacrylate) and poly(-caprolactone). Langmuir 23: 2339-2345. DOI ScienceOn |
21 | Shim, Y. H., F. Bougard, R. Lazzaroni, and P. Dubois. 2008. Synthesis and aqueous solution properties of 2-(dimethylamino)ethyl methacrylate based (co)polymers: Viscometric and AFM analysis. Eur. Pol. J. 44: 3715-3723. DOI ScienceOn |
22 | Lavasanifar, A., J. Samuel, S. Sattari, and G. S. Kwon. 2002. Block copolymer micelles for the encapsulation and delivery of amphotericin B. Pharm. Res. 19: 418-422. DOI ScienceOn |
23 | Legrand, P., E. Romero, J. P. Devissaguet, C. B. Eleazar, and J. Bolard. 1992. Effects of aggregation and solvent on toxicity of amphotericin B to human erythrocytes. Antimicrob. Agents Chemother. 36: 2518-2522. DOI ScienceOn |
24 | Mouton, J. W., D. T. Te Dorsthorst, J. F. Meis, and P. E. Verweij. 2009. Dose-response relationships of three amphotericin B formulations in a non-neutropenic murine model of invasive aspergillosis. Med. Mycol. 29: 1-7. |
25 | Vandermeulen, G., L. Rouxhet, A. Arien, M. E. Brewster, and V. Preat. 2006. Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(-caprolactone-co-trimethylenecarbonate) polymeric micelles. Int. J. Pharm. 309: 234-240. DOI ScienceOn |
26 | Walsh, T. J., J. Hiemenz, and E. Anaissie. 1996. Recent progress and current problems in treatment of invasive fungal infections in neuropenic patients. Infect. Dis. Clin. North Am. 10: 365-400. DOI ScienceOn |
27 | Yu, B., T. Okano, K. Kataoka, S. Sardari, and G. Kwon. 1998. In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(betabenzyl-L-aspartate) micelles. J. Control. Release 56: 285-291. DOI ScienceOn |
28 | Yardley, V. and S. J. Croft. 1997. Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis. Antimicrob. Agents Chemother. 41: 752-756. |